{"slug":"semax-statins","title":"semax statins","body":"## Regeneration vs degeneration — where this fits\n\nstatins represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether semax mechanisms address underlying repair deficits.\n\n## What is known\n\nStudied for BDNF and neural support — building connections, not sedating symptoms.\n\nTarget condition: statins.\nBody system: Lipid management; debated cognitive/muscle side effects in subset..\n\n## Logic chain\n\n1. semax studied for bdnf and neural support — building connections, not sedating symptoms..\n2. statins involves lipid management; debated cognitive/muscle side effects in subset. dysfunction.\n3. If semax reaches the affected tissue, it may shift the repair/breakdown balance.\n4. This chain is tested in animal or lab models only.\n\n## Parent peptide claims relevant here\n\n- In rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression.\n- In a study of 110 patients after ischemic stroke, Semax increased plasma BDNF levels.\n- Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.\n- 2025 study showing Semax improves cognitive functions in transgenic Alzheimer's disease mouse model.\n- 2025 study on Semax for spinal cord injury recovery in mice.\n\n## Evidence tier\n\nPreclinical — animal and in vitro studies only. No published human trials for this specific combination.\n\n## What we do not know\n\n- Whether semax reaches statins tissue at functional concentrations\n- Optimal dosing, route, and duration for this target\n- Interaction with standard-of-care treatments for statins\n- Long-term safety profile in this population\n\n## Safety note\n\nAll peptide use for statins is research-context only. Not medical advice. Consult a physician before any experimental compound.","register":"standard","tags":["peptide"],"style":{},"claims":[{"id":"c_map_semax-statins","text":"Combinatorial mapping (transparent): semax vs statins — regen=0.59, degen=0.45, Δ=0.14. Method: layer_relevance(0.60) × evidence_factor(0.85); catalog.degen_score for Statins.","section":"what_is_known","tier":"system"}],"sources":[],"prov":{"model":"grok/grok-4.3","action":"write"}}